Intended for healthcare professionals

Letters Statins for primary prevention

False assumptions in NICE guidance on lipid modification

BMJ 2019; 367 doi: (Published 26 November 2019) Cite this as: BMJ 2019;367:l6602
  1. Amrit Takhar, general practitioner
  1. Wansford and Kings Cliffe Practice, Wansford PE8 6PL, UK
  1. amrit.takhar{at}

A key message from Byrne and colleagues’ article on statins for the primary prevention of cardiovascular disease is that “uncertainty remains about the benefits of their use for primary prevention.”1 This is a worrying conclusion, as implementing NICE guidance takes up an enormous amount …

View Full Text

Log in

Log in through your institution


* For online subscription